2026 Volume 49 Issue 11 Pages 1894-1905
Berberine is a quaternary benzylisoquinoline alkaloid found in various medicinal plants, including species of Coptis, Phellodendron, and Berberis. Berberine exerts anti-inflammatory effects and lowers blood glucose, cholesterol, and triglyceride levels, suggesting its potential for preventing lifestyle-related diseases. This study investigated the effects of 23 berberine derivatives on adipocyte differentiation and lipid accumulation in 3T3-L1 cells. At 1 μM, several berberine derivatives markedly inhibited lipid accumulation during adipocyte differentiation without affecting cell viability, and seven of these derivatives demonstrated inhibitory activity comparable to that observed with 4 μM berberine. Notably, 13-ethylberberine iodide (1), 13-allylberberine bromide (9), and 8-n-butylberberine bromide (19) exhibited dose-dependent inhibitory effects. These derivatives (1, 9, and 19) significantly suppressed the expression of adipocyte marker genes, including peroxisome proliferator-activated receptor γ2 (Pparγ2), CCAAT/enhancer binding protein α, and adipocyte fatty acid binding protein. Further analysis revealed that these derivatives reduced early differentiation-associated cell proliferation, Pparγ2 expression, and PPARγ2 transcriptional activity. Thus, these derivatives may represent promising candidates for developing agents that modulate adipocyte differentiation and lipid accumulation.